Cargando…
“Is a cure in my sight?” Multi-stakeholder perspectives on phase I choroideremia gene transfer clinical trials
PURPOSE: Ocular gene transfer clinical trials are raising patient hopes for the treatment of choroideremia – a blinding degenerative retinopathy. Phase I choroideremia gene transfer trials necessitate communicating about the risks of harm and potential benefits with patients while avoiding the sensa...
Autores principales: | Benjaminy, Shelly, MacDonald, Ian, Bubela, Tania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018498/ https://www.ncbi.nlm.nih.gov/pubmed/24071795 http://dx.doi.org/10.1038/gim.2013.148 |
Ejemplares similares
-
Ocular gene transfer in the spotlight: implications of newspaper content for clinical communications
por: Benjaminy, Shelly, et al.
Publicado: (2014) -
Molecular genetic diagnostic techniques in choroideremia
por: Furgoch, Mira J.B., et al.
Publicado: (2014) -
Validating Ellipsoid Zone Area Measurement With Multimodal Imaging in Choroideremia
por: Zhai, Yi, et al.
Publicado: (2021) -
Genetic and phenotypic characteristics of three Mainland Chinese families with choroideremia
por: Zhou, Qi, et al.
Publicado: (2012) -
A Case Study of Choroideremia and Choroideremia Carrier
por: Pidro, Ajla, et al.
Publicado: (2019)